Koninklijke Philips (RYLPF) Total Current Liabilities (2009 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Total Current Liabilities of $8.7 billion in Q1 2026, little changed quarter-over-quarter from $8.7 billion in Q4 2025, and up 22.42% on a YoY basis from $7.1 billion in Q1 2025.
Koninklijke Philips (RYLPF) Total Current Liabilities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Total Current Liabilities history runs 18 years deep, the most recent figure standing at $8.7 billion for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 22.42% year-over-year to $8.7 billion; the TTM figure through Mar 2026 stood at $8.7 billion (up 22.42% YoY), while the FY2025 annual figure was $8.7 billion, changed 0.41% from the prior year.
- Total Current Liabilities was $8.7 billion for Q1 2026 at Koninklijke Philips, roughly flat from $8.7 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $9.4 billion in Q2 2024 to a low of $7.1 billion in Q1 2025.
- Historically, Total Current Liabilities has averaged $8.5 billion across 5 years, with a median of $8.7 billion in 2024.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities slipped 14.84% in 2022, then gained 22.42% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $8.1 billion in 2022, then climbed by 10.15% to $8.9 billion in 2023, then slipped by 2.37% to $8.7 billion in 2024, then increased by 0.41% to $8.7 billion in 2025, then declined by 0.47% to $8.7 billion in 2026.
- The last three Total Current Liabilities figures came in at $8.7 billion (Q1 2026), $8.7 billion (Q4 2025), and $8.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | 8.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.70 Bn |
| Dec 31, 2025 | 8.74 Bn |
| Sep 30, 2025 | 8.22 Bn |
| Jun 30, 2025 | 8.15 Bn |
| Mar 31, 2025 | 7.11 Bn |
| Dec 31, 2024 | 8.70 Bn |
| Jun 30, 2024 | 9.43 Bn |
| Dec 31, 2023 | 8.92 Bn |
| Jun 30, 2023 | 8.79 Bn |
| Dec 31, 2022 | 8.09 Bn |
| Jun 30, 2022 | 9.00 Bn |
| Dec 31, 2021 | 8.52 Bn |
| Jun 30, 2021 | 10.56 Bn |
| Dec 31, 2020 | 9.22 Bn |
| Jun 30, 2020 | 8.25 Bn |
| Dec 31, 2019 | 7.72 Bn |
| Jun 30, 2019 | 8.01 Bn |
| Dec 31, 2018 | 9.07 Bn |
| Jun 30, 2018 | 8.50 Bn |
| Dec 31, 2017 | 8.08 Bn |